News

The Pistoia Alliance is launching two complementary initiatives to transform pharmacovigilance (PV) in response to growing ...
November 29, 2022 Clinigen adds pharmacovigilance capabilities with acquisition of Drug Safety Navigator Clinigen Limited (‘Clinigen’ or the ‘Company’), the global pharmaceutical services ...
EVERSANA has launched a new pharmacovigilance (PV) platform that answers the need to apply advanced data analytics and ...
In this episode presented by IQVIA, BioSpace's head of insights Lori Ellis discusses the evolving role of local qualified ...
Reven Selects Its Service Provider in Pharmacovigilance, Safety Monitoring, QA, and Regulatory Affairs for Its Upcoming COVID-19 Clinical Trial ...
Robert leads Oracle’s Safety customer engagement programs, including the Safety Consortium and strategic Lighthouse Customer programs. Through these programs, Oracle strives to collaborate with ...
The rebranding follows the company’s integration into the Fishawack group of companies, a global specialist in medical communications services. Founded in 1997 in Zofingen, Switzerland, Fishawack ...
As you can read in our full report, “Unlocking the Power of Pharmacovigilance: An Adaptive Approach to an Evolving Drug Safety Environment,” we suggest that firms can address challenges to ...
The Global Pharmacovigilance and Drug Safety Software Market size is projected to grow from USD 8.35 Billion in 2022 to USD 20.27 Billion by 2030, at a Compound Annual Growth Rate (CAGR) of 11.6% ...
Useful links Further event detailsMore information about the event Speakers GIOVANNI FURLAN Safety Risk Lead - Director Pfizer, Italy MATE A. BALAZS Country Head - Patient Safety Novartis, Hungary ...